Getinge announces its Q3 Report 2022 on October 19 at 08:00 CEST followed by a conference call at 10:00 CEST
Getinge will issue its Q3 Report 2022 on October 19, 2022, at 08:00 CEST, followed by a conference call at 10:00 CEST, hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO.
Fund managers, analysts and media are invited to participate in the conference call. Please see dial in details below to join the conference:
SE: +46856642705
UK: +443333009030
US: +16467224903
During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://ir.financialhearings.com/getinge-q3-2022
Alternatively, use the following link to download the presentation: https://www.getinge.com/int/about-us/investors/reports-presentations/
Agenda
09:45 Dial in to the conference
10:00 Presentation
10:30 Q&A
11:00 End of conference
Recording available for 3 years
A recorded version can be accessed for 3 years via https://ir.financialhearings.com/getinge-q3-2022.
Contact information
Lars Mattsson, Head of Investor Relations
Phone: +46(0)10 335 0043
E-mail: [email protected]
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in 135 countries.
